MedPath

Ottawa Hospital Research Institute

Ottawa Hospital Research Institute logo
🇨🇦Canada
Ownership
Private
Established
2001-01-01
Employees
5K
Market Cap
-
Website
http://www.ohri.ca

A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers

Phase 1
Withdrawn
Conditions
Hepatitis C
Hypertension
Interventions
First Posted Date
2012-03-09
Last Posted Date
2015-01-09
Lead Sponsor
Ottawa Hospital Research Institute
Registration Number
NCT01549496
Locations
🇨🇦

Clinical Investigation Unit, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

Renin and Aldosterone Levels in the Preterm Neonate At Risk for Hypertension

Completed
Conditions
Infants Small for Gestational Age
Hypertension
Diabetes
Interventions
Other: presence of maternal risk factor for hypertension
First Posted Date
2012-03-09
Last Posted Date
2015-10-22
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
76
Registration Number
NCT01549444
Locations
🇨🇦

Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada

🇨🇦

The Ottawa Hospital, Ottawa, Ontario, Canada

A Phase II Study of Degarelix in the Management of Non-Metastatic Hormone-Refractory Prostate Cancer

Phase 2
Terminated
Conditions
Prostatic Neoplasms
Interventions
First Posted Date
2012-03-07
Last Posted Date
2020-05-07
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
5
Registration Number
NCT01545882
Locations
🇨🇦

Princess Margeret Hospital, Toronto, Ontario, Canada

🇨🇦

London Regional Cancer Centre, London, Ontario, Canada

🇨🇦

Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

Hip Impingement - Understanding Cartilage Damage

Not Applicable
Active, not recruiting
Conditions
Femoroacetabular Impingement
Interventions
Radiation: MRI
Radiation: qCT
Other: Motion Analysis
Radiation: PET-MRI
First Posted Date
2012-03-07
Last Posted Date
2024-01-05
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
70
Registration Number
NCT01546493
Locations
🇨🇦

The Ottawa Hospital, Ottawa, Ontario, Canada

Penicillin Therapeutic Drug Monitoring in the Treatment of Infectious Syphilis.

Terminated
Conditions
Early-Latent Syphilis
Syphilis
Secondary Syphilis
Primary Syphilis
Interventions
Drug: Regular Treatment for Syphilis
First Posted Date
2012-02-28
Last Posted Date
2018-04-06
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
25
Registration Number
NCT01540227
Locations
🇨🇦

The Ottawa Hospital, Ottawa, Ontario, Canada

🇨🇦

Ottawa Sexual Health Clinic/GayZone, Ottawa, Ontario, Canada

🇨🇦

Toronto General Hospital, Toronto, Ontario, Canada

Renal Hypothermia During Partial Nephrectomy

Not Applicable
Conditions
Kidney Diseases
Cancer
Renal Impairment
Hypothermia
Kidney Cancer
Urologic Diseases
Interventions
Procedure: Renal hypothermia
First Posted Date
2012-02-09
Last Posted Date
2016-10-27
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
184
Registration Number
NCT01529658
Locations
🇨🇦

London Health Science Centre, London, Ontario, Canada

🇨🇦

St. Joseph's Healthcare, Hamilton, Ontario, Canada

🇨🇦

Capital Disctrict Health Authority, Halifax, Nova Scotia, Canada

and more 3 locations

Strategies to Improve Asthma and Treatment of Asthma in Canadians

Completed
Conditions
Asthma
First Posted Date
2012-02-02
Last Posted Date
2016-03-31
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
701
Registration Number
NCT01525381
Locations
🇨🇦

Ottawa Hospital, Ottawa, Ontario, Canada

Smoking Cessation With the Ottawa Model and SmartCard in Out-patient Respirology Clinic Setting

Not Applicable
Completed
Conditions
Smoking Cessation
Interventions
Behavioral: Ottawa Model with SmartCard
Behavioral: Usual care
First Posted Date
2011-12-20
Last Posted Date
2024-01-19
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
49
Registration Number
NCT01495689
Locations
🇨🇦

The Ottawa Hospital, General Campus, Ottawa, Ontario, Canada

Atrial Fibrillation Without Hemodynamic Instability in the Intensive Care Unit

Phase 4
Completed
Conditions
Atrial Fibrillation
Interventions
Drug: Placebo
First Posted Date
2011-10-28
Last Posted Date
2014-09-15
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
25
Registration Number
NCT01461733

A Study to Evaluate the Safety of Withholding Anticoagulation in Patients With Subsegmental PE Who Have a Negative Serial Bilateral Lower Extremity Ultrasound

Completed
Conditions
Subsegmental (Single or Multiple) Pulmonary Embolism
First Posted Date
2011-10-20
Last Posted Date
2021-05-28
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
292
Registration Number
NCT01455818
Locations
🇨🇭

Geneva Hospital, Geneva, Switzerland

🇨🇦

Capital District Health Authority, Halifax, Nova Scotia, Canada

🇨🇦

Hamilton General Hospital, Hamilton, Ontario, Canada

and more 6 locations
© Copyright 2025. All Rights Reserved by MedPath